Stocks:
5,167
ETFs:
2,288
Exchanges:
11
Market Cap:
$62.23T
24h Vol:
$10.73B
Dominance:
MSFT:4.87%
Stocklytics Platform
Instrument logo  PTIX
Protagenic Therapeutics
PTIX
44 / 100
Penny Stock
$1.57arrow_drop_up25.60%$0.32

Performance History

Stocklytics logo
Key Stats
Open$1.38
Prev. Close$1.37
EPS-1.15
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap5721317.00
PE Ratio-
LOWHIGH
Day Range1.25
1.38
52 Week Range0.68
2.32
Ratios
P/B Ratio1.74
Revenue-
Operating M. %0.00%
Earnings$0.00
Earnings Growth %-40.64%
EBITDA Margin %-
ROE %-94.48%
EPS-1.15

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

44vs 54. Market Avg.

All Score 44 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

PTIXMARKET
Value6839
Quality2940
Ownership1317
Growth3646
Dividends-38
check_circle

Protagenic Therapeutics's Price discount from all time high of 100% is great compared to market average of 43.18%. This indicates PTIX could be a good value stock.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$726.31
24H (%)arrow_drop_down2.63%
24H ($)-$19.64
MARKET CAP$690.55B
PRICE$501.13
24H (%)arrow_drop_up1.61%
24H ($)$7.95
MARKET CAP$462.00B
PRICE$147.91
24H (%)arrow_drop_up1.48%
24H ($)$2.17
MARKET CAP$356.43B
PRICE$125.78
24H (%)arrow_drop_up0.43%
24H ($)$0.55
MARKET CAP$318.60B

About Protagenic Therapeutics (PTIX)

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company's lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.

Sector
Healthcare
Industry
Biotechnology
CEO
-
Headquarters
New York
Employees
0
Exchange
NASDAQ
add Protagenic Therapeutics to watchlist

Keep an eye on Protagenic Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Protagenic Therapeutics's (PTIX) price per share?

The current price per share for Protagenic Therapeutics (PTIX) is $1.29. The stock has seen a price change of -$0.08 recently, indicating a -5.84% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Protagenic Therapeutics (PTIX)?

For Protagenic Therapeutics (PTIX), the 52-week high is $2.32, which is 79.84% from the current price. The 52-week low is $0.68, the current price is 89.71% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Protagenic Therapeutics (PTIX) a growth stock?

Protagenic Therapeutics (PTIX) has shown an average price growth of -53.37% over the past three years. It has received a score of 5 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Protagenic Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Protagenic Therapeutics (PTIX) stock price performance year to date (YTD)?

As of the latest data, Protagenic Therapeutics (PTIX) has a year-to-date price change of 40.22%. Over the past month, the stock has experienced a price change of -16.77%. Over the last three months, the change has been 38.71%. Over the past six months, the figure is 51.76%.

help
Is Protagenic Therapeutics (PTIX) a profitable company?

Protagenic Therapeutics (PTIX) has a net income of -$5M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$4.53M. Furthermore, the EBITDA is -$4.5M.

help
What is the market capitalization of Protagenic Therapeutics (PTIX)?

Protagenic Therapeutics (PTIX) has a market capitalization of $5.72M. The average daily trading volume is 3.86K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.